Scinai Immunotherapeutics (SCNI) Other Non-Current Assets (2015 - 2025)
Scinai Immunotherapeutics (SCNI) posted Other Non-Current Assets of $150000.0 for Q4 2025, up 5.63% sequentially from $142000.0 in Q2 2025, and up 14.5% YoY from $131000.0 in Q4 2024.
Scinai Immunotherapeutics (SCNI) Other Non-Current Assets (2015 - 2025) Analysis & Trends
Scinai Immunotherapeutics has reported Other Non-Current Assets for 11 years, with the latest figure at $150000.0 in Q4 2025.
- Quarterly Other Non-Current Assets rose 14.5% year-over-year to $150000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $150000.0 (up 14.5% YoY) and the FY2025 annual result came in at $150000.0, up 14.5% from the prior year.
- Other Non-Current Assets rose to $150000.0 in Q4 2025 per SCNI's latest filing, from $142000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $437.0 million in Q2 2021 and troughed at $126000.0 in Q2 2023.
- A 5-year average of $58.3 million and a median of $140000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2021 and 2025: Other Non-Current Assets slumped 99.97% in 2021, then advanced 14.5% in 2025.
- Over 5 years, Other Non-Current Assets stood at $143000.0 in 2021, then decreased by 2.1% to $140000.0 in 2022, then changed by 0.0% to $140000.0 in 2023, then decreased by 6.43% to $131000.0 in 2024, then climbed by 14.5% to $150000.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $150000.0, $142000.0, and $131000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 150,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Dec 31, 2024 | 131,000.00 |
| Jun 30, 2024 | 138,000.00 |
| Dec 31, 2023 | 140,000.00 |
| Jun 30, 2023 | 126,000.00 |
| Mar 31, 2023 | 127,000.00 |
| Dec 31, 2022 | 140,000.00 |
| Sep 30, 2022 | 137,000.00 |
| Jun 30, 2022 | 138,000.00 |
| Mar 31, 2022 | 140,000.00 |
| Dec 31, 2021 | 143,000.00 |
| Sep 30, 2021 | 138,000.00 |
| Jun 30, 2021 | 437.00 Mn |
| Mar 31, 2021 | 436.00 Mn |
| Dec 31, 2020 | 473.00 Mn |
| Sep 30, 2020 | 259,000.00 |
| Jun 30, 2020 | 891.00 Mn |
| Mar 31, 2020 | 899.00 Mn |
| Dec 31, 2019 | 148,000.00 |